Skip to main content
Signal8

Nguyen Tuan

SEC insider (Form 3/4/5 filer). CIK 0002063445. Chief Financial Officer at Arbutus Biopharma Corp (ABUS). 7 reported Form 4/5 transactions since Sep 2024; latest on Oct 1, 2026. Located in WARMINSTER, PA.

Companies Nguyen Tuan has filed insider reports for

  • Arbutus Biopharma Corp (ABUS): Officer, Chief Financial Officer
Nguyen Tuan profile photo

Nguyen Tuan

CIK: 0002063445

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)2 (28.6%)

Derivative conversions

Awards (A)3 (42.9%)

Compensation grants

Other (G, F, J, C, D, …)2 (28.6%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Arbutus Biopharma Corp logo
ABUS

Arbutus Biopharma Corp

Officer

Discretionary Trading P&L

Holdings

Transaction History (7 total)

  • Arbutus Biopharma Corp logo
    ABUS

    Arbutus Biopharma Corp

    Oct 1, 2026
    Disposition
    Direct
    48.1K shares at avg. $5.00$240K
  • Arbutus Biopharma Corp logo
    ABUS

    Arbutus Biopharma Corp

    Sep 18, 2026
    Exercise
    Direct
    265.6K shares at avg. $3.49$927K
  • Arbutus Biopharma Corp logo
    ABUS

    Arbutus Biopharma Corp

    Sep 18, 2026
    Exercise
    Direct
    27.5K shares at avg. $4.39$121K
  • Arbutus Biopharma Corp logo
    ABUS

    Arbutus Biopharma Corp

    Sep 18, 2026
    Tax Payment
    Direct
    206.6K shares at avg. $5.07$1.0M
  • Arbutus Biopharma Corp logo
    ABUS

    Arbutus Biopharma Corp

    Feb 2, 2026
    Award
    Direct
    73.5K shares-
  • Arbutus Biopharma Corp logo
    ABUS

    Arbutus Biopharma Corp

    Mar 31, 2025
    Award

    Stock Option (Right to Buy)

    Direct
    750K shares-
  • Arbutus Biopharma Corp logo
    ABUS

    Arbutus Biopharma Corp

    Mar 31, 2025
    Award

    Stock Option (Right to Buy)

    Direct
    750K shares-

1-7 of 7